Lung Cancer Clinical Trials: Advances in Immunotherapy
New treatments for lung cancer and aspects of joining a clinical trial are discussed in this 30-minute Facebook Live event, hosted by NCI’s Dr. Shakun Malik, head of thoracic oncology therapeutics, and Janet Freeman-Daily, lung cancer patient activist and founding member of #LCSM.
![](/sites/g/files/xnrzdm211/files/oembed_thumbnails/UaEgqBsHTxWY7DgTnQ-DBWxAr0IYe4D3XZMbZZxsmew.jpg)
Lung Cancer Clinical Trials: Advances in Immunotherapy